NCT06861777 2025-03-11
Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3 Not yet recruiting
Clinical Trials
1 trialsInterventional × Esophageal Squamous Cell Carcinoma × Clinical Trials, Phase II as Topic × Clear all